妊娠期糖尿病患者血清miR-15a和MIF水平及其与母婴不良结局的关系

Serum miR-15a and MIF levels and their relationship with adverse maternal and infant outcomes in patients with gestational diabetes mellitus

目的探讨妊娠期糖尿病(GDM)患者血清微小核糖核酸-15a(miR-15a)和巨噬细胞迁移抑制因子(MIF)水平及其与母婴不良结局的关系。方法选取2020年1月至2022年12月于衡水市第四人民医院产检并分娩的106例GDM患者为实验组,另选取同期在该院进行孕检并分娩的健康女性106例作为对照组。采用实时荧光定量聚合酶链反应检测血清miR-15a水平,采用酶联免疫吸附试验法检测血清MIF水平。两组血清MIF和miR-15a水平进行比较,并进行多因素Logistic回归分析miR-15a和MIF水平与GDM患者发生母婴(母体、围生儿)不良结局的关系。结果实验组血清miR-15a和MIF水平高于对照组,差异有统计学意义(P<0.05)。实验组发生母婴不良结局患者的年龄>35岁、孕前体重指数>24 kg/m^(2)、有不良孕产史、血糖控制不良占比和血清MIF和miR-15a水平高于实验组发生母婴良好结局患者,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,年龄>35岁、孕前体重指数>24 kg/m^(2)、有不良孕产史、血糖控制不良及血清miR-15a和MIF均为实验组发生母婴不良结局的危险因素(P<0.05)。结论GDM患者血清miR-15a和MIF水平异常升高,且血清miR-15a和MIF水平与患者发生母婴不良结局密切相关。

Objective To investigate the serum micro-ribonucleic acid-15a(miR-15a)and macrophage migration inhibitory factor(MIF)levels and their relationship with adverse maternal and infant outcomes in patients with gestational diabetes mellitus(GDM).Methods From January 2020 to December 2022,106 patients with GDM who underwent prenatal examination and gave birth in the Hengshui Fourth People's Hospital were selected as the experimental group.Another 106 healthy women who underwent pregnancy examination and delivered in a hospital during the same period were selected as the control group.Detection of serum miR-15a level by real-time fluorescent quantitative polymerase chain reaction and serum MIF levels were detected by enzyme-linked immunosorbent assay.Serum MIF and miR-15a levels were compared between the two groups,and the relationship between miR-15a and MIF levels and adverse maternal and infant outcomes in GDM patients was analyzed by multivariate Logistic regression.Results The serum levels of miR-15a and MIF in the experimental group were higher than those in the control group,the difference was statistically significant(P<0.05).The age of patients with adverse maternal and infant outcomes in the experimental group was>35 years old,the pre-pregnancy body mass index was>24 kg/m^(2),the proportion of patients with adverse pregnancy history,poor blood glucose control and serum MIF and miR-15a levels were higher than those with good maternal and infant outcomes in the experimental group,and the differences were statistically significant(P<0.05).Multivariate Logistic regression analysis showed that age>35 years old,pre-pregnancy body mass index>24 kg/m^(2),adverse pregnancy history,poor blood glucose control and serum miR-15a and MIF were all risk factors for adverse maternal and infant outcomes in the experimental group(P<0.05).Conclusion Serum miR-15a and MIF levels are abnormally elevated in GDM patients,and serum miR-15a and MIF levels are closely related to adverse maternal and infant outcomes.